poisar

Stocks · News reference

Levi Strauss, Ionis Pharmaceuticals, Gloo Holdings And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

Avi Kapoor

U.S. stock futures mixed, Dow down 0.1%. Levi Strauss shares down 6.1%, Noah Holdings down 14%, Ionis Pharma down 12.4%, and others also falling.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

AZNDCXGLOOHASIIONSLEVILPLMDANOAHPKX
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  2. Benzinga Newsdesk

    The FDA Accepts And Grants Priority Review to AstraZeneca’s Supplemental Biologics License Application For Imfinzi (Durvalumab) Combined With Enfortumab Vedotin For Muscle-invasive Bladder Cancer Who Are Ineligible For Or Have Declined Cisplatin-based Chemotherapy

    https://www.astrazeneca.com/media-centre/press-releases/2026/perioperative-imfinzi-plus-neoadjuvant-enfortumab-vedotin-granted-priority-review-in-the-us-for-patients-with-muscle-invasive-bladder-cancer.html

    AZN
  3. Na

    Ionis Delivers Positive Late-Stage Results for Two Partnered Drugs

    Ionis Pharmaceuticals announced positive phase III results for two partnered programs: ulefnersen (FUSION study) for FUS-ALS met its primary endpoint with Otsuka planning regulatory discussions, and sefaxersen (IMAgINATION study) for IgAN showed statistically significant proteinuria reductions with Roche continuing the trial. These wins come after recent clinical setbacks in cardiovascular programs but follow FDA approval of Zanvastro for Alexander disease.

    IONSRHHBYAZNNVS